Systematic review / meta-analysis / 2020
Salt substitutes lower systolic and diastolic blood pressure in stage 2 hypertension.
A meta-analysis of 10 studies with 11 randomized controlled trials and 1,119 participants assessed salt substitutes in stage 2 hypertension. Salt substitutes reduced systolic blood pressure by a weighted mean difference of -8.87 mmHg (95% CI: -11.19 to -6.55) and diastolic blood pressure by -4.04 mmHg (95% CI: -5.70 to -2.39). Diastolic reductions were observed in adults under 65 years but not in participants aged 65 and older.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 1,119 participants with stage 2 hypertension across 11 trials
- What was measured
- Systolic and diastolic blood pressure
THE PAPER
The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis.
Jafarnejad S, Mirzaei H, Clark CCT, Taghizadeh M, Ebrahimzadeh A. BMC Cardiovasc Disord, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.